HEALSea Nasal Spray for Prevention of Infections in Children

Clinical trial NCT06582589 · COMPLETED

Trial details

NCT number: NCT06582589
Sponsor: Lallemand Pharma AG
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2024-11-25
Primary completion: 2025-04-23
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.